Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Histone deacetylases (HDACs) and histone acetylases (HATs) are enzymes that are responsible for deacetylating and acetylating, respectively, the amino-terminal tails of histones. These chromatin changes regulate transcription and many other nuclear events.
Non-histone proteins (such as the oncosuppressor p53) and several cytoplasmi...
Alternative Titles
Full title
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67608374
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67608374
Other Identifiers
ISSN
1474-175X
E-ISSN
1474-1768
DOI
10.1038/nrc1779
